Cited 4 times in
Induction of severe systemic lupus erythematosus by TNF blockade and response to an anti-IL-6 strategy: Role of IL-17?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신재일 | - |
dc.date.accessioned | 2014-12-18T09:32:23Z | - |
dc.date.available | 2014-12-18T09:32:23Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0091-6749 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/88358 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use* | - |
dc.subject.MESH | Antibodies, Monoclonal/adverse effects* | - |
dc.subject.MESH | Antibodies, Monoclonal, Humanized/therapeutic use* | - |
dc.subject.MESH | Endocarditis/drug therapy* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Interleukin-6/antagonists & inhibitors* | - |
dc.subject.MESH | Lupus Erythematosus, Systemic/drug therapy* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Tumor Necrosis Factor-alpha/antagonists & inhibitors* | - |
dc.title | Induction of severe systemic lupus erythematosus by TNF blockade and response to an anti-IL-6 strategy: Role of IL-17? | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학) | - |
dc.contributor.googleauthor | Jae Il Shin | - |
dc.identifier.doi | 10.1016/j.jaci.2013.08.004 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02142 | - |
dc.relation.journalcode | J01228 | - |
dc.identifier.eissn | 1097-6825 | - |
dc.identifier.pmid | 24176686 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0091674913012207 | - |
dc.subject.keyword | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use* | - |
dc.subject.keyword | Antibodies, Monoclonal/adverse effects* | - |
dc.subject.keyword | Antibodies, Monoclonal, Humanized/therapeutic use* | - |
dc.subject.keyword | Endocarditis/drug therapy* | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Interleukin-6/antagonists & inhibitors* | - |
dc.subject.keyword | Lupus Erythematosus, Systemic/drug therapy* | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Tumor Necrosis Factor-alpha/antagonists & inhibitors* | - |
dc.contributor.alternativeName | Shin, Jae Il | - |
dc.contributor.affiliatedAuthor | Shin, Jae Il | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 132 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1257 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol.132(5) : 1257, 2013 | - |
dc.identifier.rimsid | 32458 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.